Pearl Steinzor

A study reveals disparities by sex, socioeconomic status, and location for colorectal cancer screenings.

Higher body size and metabolic factors are linked to worse psoriasis and lower biologic treatment success.

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies for colorectal cancer.

Kavita Nair, PhD, FAAN, discusses the rising global burden of neurodegenerative diseases.

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.

A new report shows Vermont, Utah, and Minnesota lead, while Louisiana, Mississippi, and Kentucky lag in Medicare performance.

Digital tools help prevent burnout, anxiety, and exhaustion among health care workers.

Tara Carlisle, MD, PhD, University of Colorado, discusses how coordinated care efforts and frequent safety monitoring are transforming early Alzheimer disease management.

CVS Pharmacy acquires stores and prescription files from over 600 Rite Aid and Bartell Drugs pharmacies.

Ken Cohen, MD, FACP, discusses the importance of expanding cognitive screening for seniors.

A 12-year study in China finds that individuals who dine out often face a higher risk of colon and rectal cancers, with obesity playing a mediating role.

Online racial discrimination, bias, and trauma are linked to anxiety and depression in Black adolescents.

Robert Andrews, CEO of the Health Transformation Alliance, addresses Medicaid rebates, cost-shifting concerns, and value-based pricing trends.

A self-help app based on cognitive behavioral therapy improved depression, self-esteem, and quality of life in adults with intellectual disabilities.

Robert Andrews, CEO of the Health Transformation Alliance, discusses the implications of the new TrumpRx platform on drug pricing policy.

A study finds rural and nonrural patients have similar follow-up times after positive stool-based DNA tests, supporting broader colorectal cancer screening access.

A 16-week Mediterranean diet reduced psoriasis severity and improved metabolic health in patients with mild to moderate psoriasis.

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

Study finds slight temperature shifts are linked to changes in physiological stress responses.

An eHealth survey revealed widespread confusion, low awareness of 2026 Medicare plan changes, and growing interest in artificial intelligence support.

The US government shutdown could lead to telehealth, ambulance payment, and insurance cost disruptions.

Experian Health’s 2025 State of Claims survey shows rising denial rates, data errors, and low artificial intelligence adoption despite providers’ belief in its potential.

Guselkumab becomes the first interleukin-23 inhibitor approved for children with plaque psoriasis or active psoriatic arthritis.

David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments.

A RAND report shows Medicare’s 3-year insulin savings model cut costs, improved access for beneficiaries, and offers lessons for future drug pricing reforms.

Evinacumab-dgnb approval expands treatment options for children with homozygous familial hypercholesterolemia (HoFH).

Stacy Knox, PharmD, BCPS, BCACP, DPLA, discusses how centralized pharmacy teams and electronic health record integration streamline prior authorizations, enhance provider efficiency, and offer patients transparent, real-time updates.

David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for patients with rare diseases.

New research highlights caregiver perspectives to improve colorectal cancer screening access for individuals with intellectual and developmental disabilities.

National survey data show rural residents are less likely to receive colorectal cancer screening, with socioeconomic and structural barriers driving the gap.